Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments.
Saved in:
| Title: | Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments. |
|---|---|
| Authors: | Furqan F; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Ahn KW; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Kaur M; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Patel J; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Ansell S; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Awan FT; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Baird J; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA., Bezerra E; Division of Hematology, Department of Internal Medicine, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA., Farooq U; Department of Medicine, University of Iowa, Iowa City, Iowa, USA., Fung H; Department of Bone Marrow Transplant and Cellular Therapy at Fox Chase Cancer Center, Temple University, Philadelphia, Pennsylvania, USA., Khurana A; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Lekakis L; Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, Florida, USA., Lutfi F; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, Kansas, USA., McCarty J; Massey Cancer Center Bone Marrow Transplant Program, Virginia Commonwealth University, Richmond, Virginia, USA., Mukherjee A; Oncology Hematology Care, Inc., Cincinnati, Ohio, USA., Nath R; Banner MD Anderson Cancer Center, Gilbert, Arizona, USA., Romancik J; Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, Georgia, USA., Schuster SJ; Lymphoma Program, Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, USA., Smith M; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Winter A; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Turtle C; Division of Hematology and Medical Oncology, University of Washington, Seattle, WA, USA., Sauter C; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Shadman M; Division of Hematology and Medical Oncology, University of Washington, Seattle, WA, USA., Herrara A; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA., Hamadani M; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. |
| Source: | American journal of hematology [Am J Hematol] 2025 Jul; Vol. 100 (7), pp. 1152-1162. Date of Electronic Publication: 2025 Apr 15. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
